How FluoroVettesTM for BioAnalysis in the Life Sciences Can Lower Capital Equipment Costs and Reduce Time To Market

8211;- ALine, Inc. (www.alineinc.com) enables researchers to perform sophisticated experiments using standard laboratory instruments for fluorescence. The FluoroVetteTM provides a platform for:

-Quicker experiments with no cuvette cleaning
-Cost reduction with fewer reagents needed due to micro-volume capacity
-Prevent analytical error due to reagent carryover
-More accuracy by eliminating cross contamination
-Cost reduction with disposable material versus costly quartz
-Easy to use with short term storage in the FluoroVetteTM
-Compatibility by Fitting standard fluorometer cuvette holder
-Enables sophisticated modern experiments with ability to embed
    Standard reagents
    Quantum dots
    Oxygen sensors

ALine, Inc'ss founder, Dr. Leanna Levine states, 's8220;By designing our products on standard platforms - the microtiter plate, the microscope slide and the standard cuvette for spectrometry, our customers do not have to purchase expensive capital equipment to realize the advantages of low volume, and integrated functionality in a disposable device. We incorporate membranes, flexible valves, and electrodes for specialty applications in the pharmaceutical, medical device, environmental and industrial markets. Our fluidic card for cell culture, which supports NASA's8217;s space biology research program, demonstrates our ability to create high 's8211;quality custom products for our customers.'s8221;




How FluoroVettesTM for BioAnalysis in the Life Sciences Can Lower Capital Equipment Costs and Reduce Time To Market



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***